ARCHIVES

NiH Conference: More Discord Than Consensus At Statement’s Presentation

This article is from The Cancer Letter archive.

Vol. 23 No. 04 | January 31, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline

November 27, 2009